Royalty Pharma plc logo

Royalty Pharma plc (RPRX)

Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
62. 32
+0.91
+1.4818%
$
27.22B Market Cap
11.13 P/E Ratio
0.84% Div Yield
2.63M Volume
3.8 Eps
$ 61.41
Previous Close
Add Transaction
Day Range
61.73 62.58
Year Range
34.08 62.58
Want to track RPRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Royalty Pharma plc (RPRX) Statistics

Valuation metrics

Market Cap 27.22B
Enterprise value 35.12B
Trailing P/E (ttm) 25.25
Forward P/E -
PEG ratio 7.35
Price/Sales (ttm) 10.64
Price/Book (mrq) 3.96
Enterprise Value/Revenue 13.85
Enterprise Value/EBITDA 20.47

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.67M
Average volume (90 days) 2.49M

Price summary

52-Week low 34.08
52-Week high 62.58
Beta -
50-Day moving average 58.66
200-Day moving average 49.74

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.93
Trailing annual dividend yield 0.0152%
5-Year annual dividend yield -
Payout ratio 0.49
Dividend Date 10 Jun 2026
Ex-Dividend Date 15 May 2026
Last split factor -
Last split Date -

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.32%
Operating margin 0.62%

Operational effectiveness

Return on assets 0.04%
Return on equity 0.12%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 5.7
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.83
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 1.88
Total debt (mrq) -
Total Debt/Equity (mrq) 1.31
Current ratio (mrq) 1.29%
Book value per share (mrq) 21.99

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -